Delivery Order SPE2DB20D9759-SPE2DB25FD5PE

Award Date 7/3/25
Potential Completion Date 7/25/25
Potential Value $35K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, with a period of performance through September 3, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $35,734.50. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS to support the recurring medical supply needs of military health facilities. This contract is part of a larger indefinite delivery contract (IDC) with DMS...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, provides for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The firm fixed-price delivery order, valued at $8,576.28, has an ultimate completion date of August 8, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, with a ceiling value of $6,837.40 and a period of performance through May 8, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, valued at up to $499,999,999, which allows the DLA to...
This federal contract award, valued at $4,288.14, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,185,173 units of the NEXPLANON 68 MG IMPLANTS pharmaceutical product. The contract is a firm fixed-price delivery order that does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
This federal contract award is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency. The $3,471.55 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has an ultimate completion date of July 1, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $42,881.40, is a delivery order to provide NEXPLANON 68 MG IMPLANTS. The contract has a firm fixed-price pricing type and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA valued...
The federal government has awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,573.45 contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is for the delivery of NEXPLANON 68 MG IMPLANTS to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,573.45 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, with an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,720.35 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS and has an ultimate completion date of August 15, 2024. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
  • SPE2DB20D9759
    Indefinite Delivery Contract
  • SPE2DB20D9759-SPE2DB25FD5PE
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,715.50 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS. The contract has a period of performance through July 25, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide. This contract positioning establishes DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 10/2/25, 10:45 AM